Together we will beat cancer


Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

Read More

Innovative cancer spinouts: 3 new projects get green light

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

Read More

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

Read More

Science Surgery: ‘Why doesn’t the immune system attack cancer cells?’

This entry is part 13 of 23 in the series Science Surgery

In this Science Surgery post Millie asks: ‘Why doesn’t the immune system attack cancer cells?’ The short answer is it does! But sometimes it needs a helping hand from exciting new treatments.

Read More

Finding common ground with arthritis could help cancer patients

Our new research partnership is exploring common ground between arthritis and cancer, which could bring benefits to patients on both sides.

Read More